Share Price and Basic Stock Data
Last Updated: February 7, 2026, 2:25 pm
| PEG Ratio | 0.32 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sicagen India Ltd operates within the Trading & Distributors industry, with a current share price of ₹56.6 and a market capitalization of ₹224 Cr. The company’s revenue from operations has shown notable fluctuations over recent periods, with sales reported at ₹895 Cr for FY 2023, a rise from ₹836 Cr in FY 2022. However, FY 2024 sales are projected to decline to ₹795 Cr, before recovering to ₹892 Cr in FY 2025. Quarterly sales figures reflect this volatility, with the highest recorded in March 2025 at ₹251.65 Cr, while the lowest was ₹166.43 Cr in June 2023. The company’s operating profit margin (OPM) stood at 3.51%, indicating a modest profitability level compared to industry benchmarks, which typically hover around 5-10%. The recent trends suggest that while Sicagen India has managed to maintain a revenue stream, its ability to sustain growth amidst market fluctuations remains uncertain.
Profitability and Efficiency Metrics
The profitability metrics for Sicagen India Ltd demonstrate both strengths and challenges. The net profit for FY 2023 was reported at ₹17 Cr, with a corresponding net profit margin of 1.91% for FY 2025. This is an improvement from a net loss of ₹1 Cr in FY 2022, reflecting a recovery trajectory. The interest coverage ratio (ICR) stood at 3.95x, indicating that the company generates sufficient earnings to cover its interest obligations, which is favorable compared to the typical sector ratio of around 2-3x. However, the return on equity (ROE) at 3.41% and return on capital employed (ROCE) at 5.57% are relatively low, suggesting that the company has not been able to efficiently utilize its capital for generating higher returns. Additionally, the cash conversion cycle (CCC) is extended at 134 days, which may indicate inefficiencies in managing working capital, a critical area for improvement.
Balance Sheet Strength and Financial Ratios
Sicagen India’s balance sheet exhibits a mixed picture. As of the latest reporting period, total reserves reached ₹478 Cr, while borrowings stood at ₹164 Cr, resulting in a debt-to-equity ratio of 0.27, which is relatively low and suggests a conservative leverage position. The company’s current ratio is reported at 2.29, indicating strong short-term liquidity, as it is above the typical benchmark of 1.5 for healthy companies. However, the book value per share has shown only modest growth, standing at ₹122.31, which is consistent but not remarkable compared to industry peers. The price-to-book value (P/BV) ratio of 0.50x indicates that the stock is trading at a significant discount to its book value, potentially making it an attractive option for value investors. Nevertheless, the company’s ability to convert its assets into revenue efficiently remains a concern, as reflected in the asset turnover ratio of 1.26.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sicagen India Ltd reveals a strong promoter presence, with promoters holding 61.13% of the equity as of September 2025. This represents a steady increase from 45.66% in December 2022, indicating growing confidence from insiders. Foreign institutional investors (FIIs) hold a modest 2.42%, a significant decline from 7.34% earlier in the year, which may suggest waning confidence from international investors. Domestic institutional investors (DIIs) account for only 0.58%, reflecting limited institutional interest. The public shareholding stands at 35.88%, showing a decrease, which could raise concerns regarding the stock’s liquidity in the market. With a total of 23,326 shareholders, the company appears to have a diverse investor base, yet the declining percentage of public and institutional holdings may impact overall market perception and investor confidence.
Outlook, Risks, and Final Insight
Looking ahead, Sicagen India Ltd faces a mixed outlook characterized by both opportunities and risks. The company’s ability to stabilize its revenue and enhance profitability will be crucial. Key strengths include a solid liquidity position and low debt levels, which provide a buffer against market volatility. However, risks such as operational inefficiencies indicated by the prolonged cash conversion cycle and low return ratios pose significant challenges. Additionally, the declining interest from institutional investors could hinder the company’s growth prospects. For investors, the attractiveness of Sicagen India lies in its undervalued stock relative to book value, presenting a potential buy opportunity if operational challenges can be addressed. However, without significant improvements in efficiency and profitability, the stock may continue to underperform relative to industry standards.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Millennium Online Solutions (India) Ltd | 7.65 Cr. | 1.53 | 2.88/1.36 | 0.81 | 0.00 % | 4.61 % | 5.54 % | 1.00 | |
| Minal Industries Ltd | 54.1 Cr. | 2.82 | 5.59/2.50 | 36.1 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 11.9 Cr. | 13.5 | 17.8/11.5 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 5.36 Cr. | 58.9 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 146 Cr. | 46.8 | 54.5/10.2 | 163 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| Industry Average | 9,451.73 Cr | 153.82 | 86.19 | 120.60 | 0.42% | 15.22% | 8.81% | 7.62 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 258.19 | 227.42 | 166.43 | 180.08 | 227.70 | 221.23 | 232.26 | 197.71 | 209.92 | 251.65 | 204.54 | 226.76 | 264.27 |
| Expenses | 251.32 | 216.05 | 157.99 | 174.97 | 222.48 | 212.85 | 222.99 | 189.44 | 203.04 | 240.91 | 194.80 | 217.70 | 255.00 |
| Operating Profit | 6.87 | 11.37 | 8.44 | 5.11 | 5.22 | 8.38 | 9.27 | 8.27 | 6.88 | 10.74 | 9.74 | 9.06 | 9.27 |
| OPM % | 2.66% | 5.00% | 5.07% | 2.84% | 2.29% | 3.79% | 3.99% | 4.18% | 3.28% | 4.27% | 4.76% | 4.00% | 3.51% |
| Other Income | 1.87 | 7.55 | 1.32 | 1.49 | 2.85 | 1.44 | 2.03 | 2.72 | 3.52 | 2.27 | 1.92 | 1.75 | 2.69 |
| Interest | 2.28 | 2.64 | 2.59 | 2.47 | 2.65 | 2.94 | 2.62 | 2.83 | 2.50 | 3.07 | 3.04 | 2.71 | 2.68 |
| Depreciation | 2.13 | 3.55 | 2.12 | 2.12 | 2.19 | 3.33 | 2.29 | 2.31 | 2.39 | 3.51 | 2.39 | 2.37 | 2.37 |
| Profit before tax | 4.33 | 12.73 | 5.05 | 2.01 | 3.23 | 3.55 | 6.39 | 5.85 | 5.51 | 6.43 | 6.23 | 5.73 | 6.91 |
| Tax % | 20.32% | 12.25% | 24.75% | 35.32% | 28.17% | 12.68% | 24.88% | 29.23% | 23.77% | 38.26% | 27.13% | 27.75% | 28.65% |
| Net Profit | 3.45 | 11.17 | 3.80 | 1.30 | 2.32 | 3.10 | 4.80 | 4.14 | 4.20 | 3.97 | 4.54 | 4.14 | 4.93 |
| EPS in Rs | 0.87 | 2.82 | 0.96 | 0.33 | 0.59 | 0.78 | 1.21 | 1.05 | 1.06 | 1.00 | 1.15 | 1.05 | 1.25 |
Last Updated: February 4, 2026, 4:46 am
Below is a detailed analysis of the quarterly data for Sicagen India Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 264.27 Cr.. The value appears strong and on an upward trend. It has increased from 226.76 Cr. (Sep 2025) to 264.27 Cr., marking an increase of 37.51 Cr..
- For Expenses, as of Dec 2025, the value is 255.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 217.70 Cr. (Sep 2025) to 255.00 Cr., marking an increase of 37.30 Cr..
- For Operating Profit, as of Dec 2025, the value is 9.27 Cr.. The value appears strong and on an upward trend. It has increased from 9.06 Cr. (Sep 2025) to 9.27 Cr., marking an increase of 0.21 Cr..
- For OPM %, as of Dec 2025, the value is 3.51%. The value appears to be declining and may need further review. It has decreased from 4.00% (Sep 2025) to 3.51%, marking a decrease of 0.49%.
- For Other Income, as of Dec 2025, the value is 2.69 Cr.. The value appears strong and on an upward trend. It has increased from 1.75 Cr. (Sep 2025) to 2.69 Cr., marking an increase of 0.94 Cr..
- For Interest, as of Dec 2025, the value is 2.68 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.71 Cr. (Sep 2025) to 2.68 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Dec 2025, the value is 2.37 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 2.37 Cr..
- For Profit before tax, as of Dec 2025, the value is 6.91 Cr.. The value appears strong and on an upward trend. It has increased from 5.73 Cr. (Sep 2025) to 6.91 Cr., marking an increase of 1.18 Cr..
- For Tax %, as of Dec 2025, the value is 28.65%. The value appears to be increasing, which may not be favorable. It has increased from 27.75% (Sep 2025) to 28.65%, marking an increase of 0.90%.
- For Net Profit, as of Dec 2025, the value is 4.93 Cr.. The value appears strong and on an upward trend. It has increased from 4.14 Cr. (Sep 2025) to 4.93 Cr., marking an increase of 0.79 Cr..
- For EPS in Rs, as of Dec 2025, the value is 1.25. The value appears strong and on an upward trend. It has increased from 1.05 (Sep 2025) to 1.25, marking an increase of 0.20.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:38 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 620 | 645 | 601 | 711 | 738 | 820 | 699 | 542 | 836 | 895 | 795 | 892 | 893 |
| Expenses | 631 | 644 | 608 | 707 | 737 | 817 | 688 | 533 | 814 | 869 | 768 | 856 | 856 |
| Operating Profit | -11 | 1 | -7 | 3 | 1 | 3 | 11 | 9 | 22 | 27 | 28 | 36 | 37 |
| OPM % | -2% | 0% | -1% | 0% | 0% | 0% | 2% | 2% | 3% | 3% | 3% | 4% | 4% |
| Other Income | 41 | 18 | 18 | 15 | 15 | 15 | 11 | 8 | -0 | 15 | 7 | 9 | 9 |
| Interest | 7 | 6 | 6 | 7 | 9 | 9 | 9 | 5 | 6 | 9 | 11 | 11 | 11 |
| Depreciation | 6 | 5 | 5 | 4 | 5 | 6 | 10 | 10 | 11 | 11 | 10 | 10 | 11 |
| Profit before tax | 17 | 8 | -1 | 8 | 2 | 3 | 3 | 1 | 5 | 22 | 14 | 24 | 24 |
| Tax % | 1% | 13% | -300% | 3% | 30% | 95% | 89% | 322% | 112% | 18% | 24% | 29% | |
| Net Profit | 17 | 7 | 1 | 7 | 1 | 0 | 0 | -3 | -1 | 18 | 11 | 17 | 17 |
| EPS in Rs | 4.27 | 1.67 | 0.27 | 1.89 | 0.29 | 0.03 | 0.09 | -0.81 | -0.15 | 4.50 | 2.66 | 4.32 | 4.26 |
| Dividend Payout % | 19% | 36% | 224% | 32% | 206% | 1,218% | 550% | -74% | -162% | 13% | 23% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -58.82% | -85.71% | 600.00% | -85.71% | -100.00% | 66.67% | 1900.00% | -38.89% | 54.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.89% | 685.71% | -685.71% | -14.29% | 166.67% | 1833.33% | -1938.89% | 93.43% |
Sicagen India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 5% |
| 3 Years: | 2% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 113% |
| 3 Years: | 136% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 45% |
| 3 Years: | 27% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:31 pm
Balance Sheet
Last Updated: February 1, 2026, 1:55 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |
| Reserves | 441 | 439 | 443 | 345 | 353 | 343 | 336 | 355 | 383 | 400 | 420 | 444 | 478 |
| Borrowings | 73 | 48 | 60 | 89 | 97 | 119 | 96 | 79 | 95 | 121 | 121 | 148 | 164 |
| Other Liabilities | 119 | 84 | 76 | 105 | 114 | 184 | 133 | 72 | 140 | 68 | 143 | 90 | 148 |
| Total Liabilities | 673 | 610 | 619 | 578 | 604 | 685 | 605 | 546 | 656 | 629 | 723 | 722 | 830 |
| Fixed Assets | 64 | 59 | 57 | 183 | 203 | 151 | 168 | 168 | 141 | 141 | 140 | 137 | 140 |
| CWIP | 0 | 1 | 2 | 12 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 |
| Investments | 100 | 100 | 100 | 54 | 34 | 26 | 20 | 37 | 70 | 69 | 73 | 79 | 93 |
| Other Assets | 509 | 451 | 460 | 329 | 367 | 507 | 417 | 340 | 445 | 418 | 510 | 505 | 596 |
| Total Assets | 673 | 610 | 619 | 578 | 604 | 685 | 605 | 546 | 656 | 629 | 723 | 722 | 830 |
Below is a detailed analysis of the balance sheet data for Sicagen India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 40.00 Cr..
- For Reserves, as of Sep 2025, the value is 478.00 Cr.. The value appears strong and on an upward trend. It has increased from 444.00 Cr. (Mar 2025) to 478.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 164.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 148.00 Cr. (Mar 2025) to 164.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 148.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.00 Cr. (Mar 2025) to 148.00 Cr., marking an increase of 58.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 830.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 722.00 Cr. (Mar 2025) to 830.00 Cr., marking an increase of 108.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Mar 2025) to 140.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 14.00 Cr..
- For Other Assets, as of Sep 2025, the value is 596.00 Cr.. The value appears strong and on an upward trend. It has increased from 505.00 Cr. (Mar 2025) to 596.00 Cr., marking an increase of 91.00 Cr..
- For Total Assets, as of Sep 2025, the value is 830.00 Cr.. The value appears strong and on an upward trend. It has increased from 722.00 Cr. (Mar 2025) to 830.00 Cr., marking an increase of 108.00 Cr..
Notably, the Reserves (478.00 Cr.) exceed the Borrowings (164.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -84.00 | -47.00 | -67.00 | -86.00 | -96.00 | -116.00 | -85.00 | -70.00 | -73.00 | -94.00 | -93.00 | -112.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 61 | 71 | 75 | 91 | 119 | 108 | 115 | 107 | 76 | 114 | 94 |
| Inventory Days | 70 | 56 | 59 | 70 | 68 | 58 | 78 | 80 | 50 | 65 | 67 | 60 |
| Days Payable | 35 | 19 | 19 | 32 | 42 | 75 | 60 | 40 | 60 | 24 | 47 | 20 |
| Cash Conversion Cycle | 110 | 98 | 110 | 113 | 117 | 102 | 126 | 155 | 97 | 117 | 134 | 134 |
| Working Capital Days | 67 | 69 | 78 | 67 | 73 | 61 | 99 | 114 | 84 | 85 | 97 | 88 |
| ROCE % | 2% | 2% | 1% | 3% | 2% | 3% | 3% | 2% | 4% | 4% | 4% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.81 |
| Diluted EPS (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.81 |
| Cash EPS (Rs.) | 6.98 | 5.12 | 7.17 | 2.61 | 1.70 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 122.31 | 116.19 | 111.08 | 106.73 | 99.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 122.31 | 116.19 | 111.08 | 106.73 | 99.75 |
| Revenue From Operations / Share (Rs.) | 225.39 | 201.02 | 226.26 | 211.31 | 136.88 |
| PBDIT / Share (Rs.) | 11.01 | 8.66 | 8.77 | 7.72 | 4.25 |
| PBIT / Share (Rs.) | 8.35 | 6.19 | 6.11 | 4.96 | 1.74 |
| PBT / Share (Rs.) | 6.11 | 3.50 | 5.47 | 1.27 | 0.36 |
| Net Profit / Share (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.80 |
| NP After MI And SOA / Share (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.80 |
| PBDIT Margin (%) | 4.88 | 4.30 | 3.87 | 3.65 | 3.10 |
| PBIT Margin (%) | 3.70 | 3.07 | 2.69 | 2.34 | 1.27 |
| PBT Margin (%) | 2.71 | 1.73 | 2.41 | 0.59 | 0.26 |
| Net Profit Margin (%) | 1.91 | 1.31 | 1.99 | -0.07 | -0.59 |
| NP After MI And SOA Margin (%) | 1.91 | 1.31 | 1.99 | -0.07 | -0.59 |
| Return on Networth / Equity (%) | 3.53 | 2.28 | 4.05 | -0.14 | -0.81 |
| Return on Capital Employeed (%) | 6.58 | 5.12 | 5.29 | 4.47 | 1.60 |
| Return On Assets (%) | 2.37 | 1.50 | 2.83 | -0.09 | -0.56 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.27 | 0.22 | 0.24 | 0.18 | 0.16 |
| Asset Turnover Ratio (%) | 1.26 | 1.20 | 1.39 | 0.85 | 0.66 |
| Current Ratio (X) | 2.29 | 2.17 | 2.38 | 2.01 | 2.57 |
| Quick Ratio (X) | 1.70 | 1.58 | 1.55 | 1.54 | 1.76 |
| Inventory Turnover Ratio (X) | 6.85 | 2.28 | 3.78 | 0.70 | 0.48 |
| Dividend Payout Ratio (NP) (%) | 13.85 | 22.59 | 5.55 | -388.52 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 8.58 | 11.69 | 3.49 | 22.96 | 0.00 |
| Earning Retention Ratio (%) | 86.15 | 77.41 | 94.45 | 488.52 | 0.00 |
| Cash Earning Retention Ratio (%) | 91.42 | 88.31 | 96.51 | 77.04 | 0.00 |
| Interest Coverage Ratio (X) | 3.95 | 3.22 | 3.91 | 5.18 | 3.08 |
| Interest Coverage Ratio (Post Tax) (X) | 2.36 | 1.98 | 2.29 | 2.37 | 0.41 |
| Enterprise Value (Cr.) | 307.23 | 291.78 | 198.21 | 139.51 | 85.90 |
| EV / Net Operating Revenue (X) | 0.34 | 0.36 | 0.22 | 0.16 | 0.15 |
| EV / EBITDA (X) | 7.05 | 8.52 | 5.71 | 4.57 | 5.10 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.29 | 0.13 | 0.10 | 0.10 |
| Retention Ratios (%) | 86.14 | 77.40 | 94.44 | 488.52 | 0.00 |
| Price / BV (X) | 0.50 | 0.50 | 0.27 | 0.20 | 0.14 |
| Price / Net Operating Revenue (X) | 0.27 | 0.29 | 0.13 | 0.10 | 0.10 |
| EarningsYield | 0.07 | 0.04 | 0.14 | -0.01 | -0.05 |
After reviewing the key financial ratios for Sicagen India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.98. This value is within the healthy range. It has increased from 5.12 (Mar 24) to 6.98, marking an increase of 1.86.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.31. It has increased from 116.19 (Mar 24) to 122.31, marking an increase of 6.12.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.31. It has increased from 116.19 (Mar 24) to 122.31, marking an increase of 6.12.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 225.39. It has increased from 201.02 (Mar 24) to 225.39, marking an increase of 24.37.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 11.01. This value is within the healthy range. It has increased from 8.66 (Mar 24) to 11.01, marking an increase of 2.35.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 6.19 (Mar 24) to 8.35, marking an increase of 2.16.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.11. This value is within the healthy range. It has increased from 3.50 (Mar 24) to 6.11, marking an increase of 2.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For PBDIT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has increased from 4.30 (Mar 24) to 4.88, marking an increase of 0.58.
- For PBIT Margin (%), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 10. It has increased from 3.07 (Mar 24) to 3.70, marking an increase of 0.63.
- For PBT Margin (%), as of Mar 25, the value is 2.71. This value is below the healthy minimum of 10. It has increased from 1.73 (Mar 24) to 2.71, marking an increase of 0.98.
- For Net Profit Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 5. It has increased from 1.31 (Mar 24) to 1.91, marking an increase of 0.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 8. It has increased from 1.31 (Mar 24) to 1.91, marking an increase of 0.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.53. This value is below the healthy minimum of 15. It has increased from 2.28 (Mar 24) to 3.53, marking an increase of 1.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.58. This value is below the healthy minimum of 10. It has increased from 5.12 (Mar 24) to 6.58, marking an increase of 1.46.
- For Return On Assets (%), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 5. It has increased from 1.50 (Mar 24) to 2.37, marking an increase of 0.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.27, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.26. It has increased from 1.20 (Mar 24) to 1.26, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.29, marking an increase of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 1.70, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.85. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 6.85, marking an increase of 4.57.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.85. This value is below the healthy minimum of 20. It has decreased from 22.59 (Mar 24) to 13.85, marking a decrease of 8.74.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 20. It has decreased from 11.69 (Mar 24) to 8.58, marking a decrease of 3.11.
- For Earning Retention Ratio (%), as of Mar 25, the value is 86.15. This value exceeds the healthy maximum of 70. It has increased from 77.41 (Mar 24) to 86.15, marking an increase of 8.74.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.42. This value exceeds the healthy maximum of 70. It has increased from 88.31 (Mar 24) to 91.42, marking an increase of 3.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.95. This value is within the healthy range. It has increased from 3.22 (Mar 24) to 3.95, marking an increase of 0.73.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 3. It has increased from 1.98 (Mar 24) to 2.36, marking an increase of 0.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 307.23. It has increased from 291.78 (Mar 24) to 307.23, marking an increase of 15.45.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 24) to 0.34, marking a decrease of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 7.05. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 7.05, marking a decrease of 1.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.29 (Mar 24) to 0.27, marking a decrease of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 86.14. This value exceeds the healthy maximum of 70. It has increased from 77.40 (Mar 24) to 86.14, marking an increase of 8.74.
- For Price / BV (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.29 (Mar 24) to 0.27, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.07, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sicagen India Ltd:
- Net Profit Margin: 1.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.58% (Industry Average ROCE: 15.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.53% (Industry Average ROE: 8.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.36
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.7
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.8 (Industry average Stock P/E: 86.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 4th Floor, SPIC House, No.88, Mount Road, Chennai (Madras) Tamil Nadu 600032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashwin C Muthiah | Chairman |
| Mr. Nandakumar Varma | Whole Time Director |
| Mr. R Chandrasekar | Director |
| Mr. Batchu Sai Purshotham | Independent Director |
| Ms. Govindarajan Dattatreyan Sharma | Independent Director |
| Ms. Rita Chandrasekar | Independent Director |
FAQ
What is the intrinsic value of Sicagen India Ltd?
Sicagen India Ltd's intrinsic value (as of 08 February 2026) is ₹65.22 which is 13.23% higher the current market price of ₹57.60, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹228 Cr. market cap, FY2025-2026 high/low of ₹79.4/49.5, reserves of ₹478 Cr, and liabilities of ₹830 Cr.
What is the Market Cap of Sicagen India Ltd?
The Market Cap of Sicagen India Ltd is 228 Cr..
What is the current Stock Price of Sicagen India Ltd as on 08 February 2026?
The current stock price of Sicagen India Ltd as on 08 February 2026 is ₹57.6.
What is the High / Low of Sicagen India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sicagen India Ltd stocks is ₹79.4/49.5.
What is the Stock P/E of Sicagen India Ltd?
The Stock P/E of Sicagen India Ltd is 12.8.
What is the Book Value of Sicagen India Ltd?
The Book Value of Sicagen India Ltd is 131.
What is the Dividend Yield of Sicagen India Ltd?
The Dividend Yield of Sicagen India Ltd is 1.73 %.
What is the ROCE of Sicagen India Ltd?
The ROCE of Sicagen India Ltd is 5.57 %.
What is the ROE of Sicagen India Ltd?
The ROE of Sicagen India Ltd is 3.41 %.
What is the Face Value of Sicagen India Ltd?
The Face Value of Sicagen India Ltd is 10.0.